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A B S T R A C T
Background: The optimal treatment strategies for acute ST-elevation myocardial infarction (STEMI) in
older patients are unclear because of the high risk of mortality in this population. Hypoalbuminemia,
frailty, and body mass index (BMI) have been reported to worsen the prognosis of some older patients
with cardiovascular disease, but the speciﬁc impact of these factors on the prognosis after STEMI is
poorly understood. The aim of this study was to investigate the impact of these factors on early outcomes
in patients aged 85 years with acute STEMI.
Methods: Sixty-two consecutive eligible patients aged 85 years (mean age, 88.1  2.5 years; age range,
85–94 years; female, 41.9%; primary percutaneous coronary intervention, 67.7%) who were admitted to our
hospital with STEMI were retrospectively reviewed. Baseline patient characteristics, echocardiographic,
electrocardiographic, and laboratory ﬁndings, and the Canadian Study of Health and Aging Clinical Frailty
Scale (CSHA-CFS) score were assessed. The primary endpoint was in-hospital mortality and the secondary
endpoint was failure of discharge to home. Independent baseline variables with a p-value of <0.15 in the
univariate analyses were included in the multivariate analyses.
Results: Multivariate analysis identiﬁed a higher baseline serum troponin I level [p = 0.046; odds ratio
(OR): 1.02], lower baseline albumin level (p = 0.035, OR: 0.16), and CSHA-CFS score 6 (p = 0.028, OR:
6.38) as independent predictors of in-hospital mortality. Lower BMI (p < 0.001, OR: 0.49) and CSHA-CFS
frailty score 6 (p = 0.002, OR: 16.69) were identiﬁed as independent predictors of failure of discharge to
home.
Conclusions: These ﬁndings indicate that the serum albumin level, CSHA-CFS score, and BMI, in addition
to serum troponin I level, have an impact on the early prognosis of older patients with STEMI.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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The optimal treatment strategies for acute ST-elevation
myocardial infarction (STEMI) in older patients are controversial
as this population is growing and carries a high risk of mortality
[1–4]. The factors known to affect outcomes after STEMI in the
general population include cardiogenic shock, unprotected left
main coronary artery occlusion, and suboptimal Thrombolysis In
Myocardial Infarction (TIMI) ﬂow grades after percutaneous* Corresponding author at: Department of Cardiology, Saitama Medical University,
1397-1 Yamane, Hidaka, Saitama 350-1298, Japan. Tel.: +81 42 984 4302;
fax: +81 42 984 4591.
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http://dx.doi.org/10.1016/j.jjcc.2014.12.001
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightscoronary intervention (PCI) [5–7]. However, there is still insufﬁ-
cient evidence regarding the factors affecting outcomes after
STEMI in older patients, as this population was not included
in most of the important pivotal randomized clinical trials
[8–10]. This lack of evidence can result in underestimation of
the risks associated with procedures that may not confer a survival
beneﬁt in a particular patient cohort.
This study investigated the impact of baseline hypoalbumine-
mia, body mass index (BMI), and frailty on early prognosis after
acute STEMI in patients aged 85 years. These factors appear to be
particularly important in determining outcomes in older patients
with cardiovascular disease, and better understanding of the roles
of these factors may help to predict outcomes and potentially to
make decisions about management strategy. Frailty is a complex
clinical syndrome of increased vulnerability to stressors [11], and reserved.
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[12]. However, the impact of frailty on outcomes after STEMI is
unclear. BMI is one of the factors used to calculate the Geriatric
Nutritional Risk Index [13]. Although the impact of BMI on
mortality after STEMI has been studied [14], the speciﬁc impact of
BMI on outcomes in older patients is not well understood.
Hypoalbuminemia, which predominantly results from malnutri-
tion, inﬂammation, or cachexia, is common in patients with heart
failure and increases in prevalence with age and illness
[15,16]. One study found that hypoalbuminemia was associated
with adverse outcomes, but not with mortality in patients with
acute coronary syndrome [17]. However, the impact of hypoalbu-
minemia on outcomes after STEMI has not been well investigated.
Older patients may be particularly vulnerable to hemodynamic
changes, and we speculated that hypoalbuminemia, frailty, and
BMI may have serious adverse effects in older patients with STEMI.
The aim of this study was to investigate the impact of these factors
on early outcomes in patients aged 85 years with acute STEMI.
Methods
Study design and population
The medical records of 65 consecutive patients aged 85 years
who were admitted to the Saitama Medical University Interna-
tional Medical Center with acute STEMI between April 2007 and
July 2014 were retrospectively reviewed. STEMI was deﬁned as: (1)
clinical evidence of ischemia, (2) echocardiogram showing new ST
elevation at the J-point in two contiguous leads, with a cut-off
point of 0.2 mV in men and 0.15 mV in women in leads V2–V3
or 0.1 mV in the other leads, and (3) at least one high myocardial
biomarker level, deﬁned as a serum troponin I or creatine kinase
level above the 99th percentile of the normal reference population
during the ﬁrst 24 h after admission [18,19]. Patients who were not
assessed for frailty (n = 3) were excluded, and the remaining
62 patients were included in the analyses.
Data collection
Baseline patient characteristics including age, sex, BMI, systolic
and diastolic blood pressure, and heart rate were recorded.
Hypertension was deﬁned as current or previous treatment with
antihypertensive medication. Diabetes mellitus was deﬁned as
current or previous treatment with antidiabetic medication
(insulin or oral hypoglycemic drugs) or a hemoglobin A1c level
of 6.5% (National Glycohemoglobin Standardization Program)
[20]. Dyslipidemia was deﬁned as current or previous treatment
with anti-dyslipidemic medication. Previous end-stage renal
disease requiring hemodialysis, myocardial infarction, congestive
heart failure, stroke, PCI, coronary artery bypass grafting, valve
surgery, and artiﬁcial pacemaker implantation were recorded
based on interviews with the patients and/or their relatives. The
initial symptoms suggestive of myocardial ischemia and the time
from onset to arrival were recorded. The laboratory ﬁndings
recorded included the baseline white blood cell count, hemoglobin
concentration, and serum levels of troponin I, creatine kinase,
creatine kinase MB isoenzyme, and albumin. The echocardio-
graphic ﬁndings recorded included the left ventricular ejection
fraction calculated by the Teichholz method and any signiﬁcant
valve disease. The electrocardiographic ﬁndings recorded included
atrial ﬁbrillation and ST segment changes; the number of leads
with ST segment elevation, the maximum amplitude of ST segment
elevation and the presumed location of infarct area were described
(see echocardiographic criteria in the Supplementary Method). The
Killip classiﬁcation was determined based on the physical
examination ﬁndings and the systolic blood pressure. Frailtywas assessed using the Canadian Study of Health and Aging Clinical
Frailty Scale (CSHA-CFS) score [21], and was classiﬁed as <6 or
6. A CSHA-CFS score of 6 indicates that help is needed with both
instrumental and non-instrumental activities of daily living.
Outcomes
The primary endpoint was in-hospital death. The secondary
endpoint was failure of discharge to home. Failure of discharge to
home was deﬁned as the composite of in-hospital mortality and
new transfer to a hospital/nursing home (transfer to a hospital/
nursing home was only considered to be failure of discharge to
home if the patient was not in a hospital/nursing home
immediately prior to admission).
Treatment protocol
On admission, patients underwent a quick evaluation that
included taking a history and performing a physical examination,
electrocardiogram, chest X-ray, echocardiogram, and blood tests.
The attending physician then decided whether to manage the
patient with primary PCI or conservative therapy (see detail in
Supplementary Method). Written informed consent was obtained
from each patient and/or the patient’s relatives before PCI. None of
the patients received systemic thrombolytic therapy.
Other therapeutic interventions were performed at the discre-
tion of the attending physician, including blood transfusion for
anemia, mechanical ventilation for respiratory failure or shock,
administration of diuretics for congestive heart failure, and
administration of inotropes for hypotension or hypoperfusion.
Statistical analysis
Continuous variables are expressed as mean  standard devia-
tion or median (ﬁrst to third quartile) and categorical variables as
number (%). Categorical variables between the groups were compared
using the x2 test or Fisher’s exact probability test. Univariate and
multivariate logistic regression analyses were performed to identify
the independent predictors of in-hospital mortality and failure of
discharge to home. Independent baseline variables with a p-value of
<0.15 in the univariate analyses were included in the multivariate
analyses.
A p-value of <0.05 was considered to be statistically signiﬁcant.
All statistical analyses were performed using JMP V.10.0.0 (SAS
Institute, Inc., Cary, NC, USA).
Ethics approval
The study was conducted according to the guideline of the
Declaration of Helsinki and was approved by the Institutional
Review Board of the International Medical Center of Saitama
Medical University (reference number 14028), who waived the
need for patient consent for inclusion.
Results
Patient characteristics
The baseline clinical characteristics of all 62 patients and the
results of univariate regression analyses for in-hospital mortality
are shown in Table 1. The mean age of the patients was
88.1  2.5 years (range, 85–94 years) and 41.9% were female.
Forty-three patients (69.4%) had hypertension, 10 (16.1%) had
diabetes mellitus, and 14 (22.6%) had dyslipidemia. The median
time from onset to arrival was 6 h (ﬁrst-third quartile: 3–12 h). The
initial symptoms suggestive of myocardial ischemia were: chest
Table 1
Univariate analyses of associations between baseline variables and in-hospital mortality.
Total (n = 62) p univariate OR 95% CI
Demographics
Age, years 88.1  2.5 0.610 0.94 0.71–1.19
Female, n (%) 26 (41.9) 0.937 1.05 0.30–3.49
BMI, kg/m2 21.0  3.3 0.107 0.82 0.63–1.02
Coexisting conditions, n (%)
Hypertension, n (%) 43 (69.4) 0.848 1.14 0.32–4.67
Diabetes mellitus, n (%) 10 (16.1) 0.829 0.83 0.12–3.91
Dyslipidemia, n (%) 14 (22.6) 0.381 0.50 0.07–2.19
ESRD on HD, n (%) 5 (8.1) 0.361 2.50 0.3–16.8
Previous MI, n (%) 7 (11.3) 0.600 0.54 0.03–3.57
Previous CHF, n (%) 14 (22.6) 0.198 2.41 0.62–8.91
Previous stroke, n (%) 10 (16.1) 0.829 0.82 0.12–3.91
Previous PCI, n (%) 7 (11.3) 0.560 0.54 0.03–3.57
Previous CABG, n (%) 2 (3.2) 0.388 3.62 0.14–95.65
Previous valve surgery, n (%) 0 (0.0) N/A N/A N/A
Previous PMI, n (%) 2 (3.2) 0.388 3.62 0.14–95.65
Findings at presentation
Time from onset to arrival, h 6 (3–12) 0.338 0.98 0.97–1.08
Systolic BP, mmHg 130.1  32.4 0.252 0.99 0.97–1.01
Diastolic BP, mmHg 71.0  21.0 0.881 1.00 0.97–1.03
Heart rate, bpm 79.9  24.7 0.587 1.01 0.98–1.03
WBC count, 103/mm3 9.9  3.5 0.130 1.14 0.96–1.36
Hemoglobin, g/dl 12.4  2.2 0.150 0.81 0.60–1.07
Troponin I, ng/ml 4.6 (0.4–25.1) 0.060 1.02 1.00–1.04
Creatinine, mg/dl 1.0 (0.8–1.5) 0.468 1.42 1.02–2.12
Creatine kinase, IU/I 246 (129–667) 0.309 1.00 1.00–1.00
Creatine kinase MB, IU/l 15 (5–42) 0.216 1.00 1.00–1.01
Albumin, g/dl 3.59  0.50 0.008* 0.16 0.03–0.57
LVEF, % 56.8  15.0 0.159 0.97 0.93–1.01
Valvular disease, n (%) 4 (6.5) 0.213 3.83 0.43–34.75
Atrial ﬁbrillation, n (%) 13 (21.0) 0.439 1.73 0.40–6.61
Number of leads with ST elevation, n 3 (2–5) 0.762 0.94 0.04–7.86
Maximum amplitude of ST elevation, mV 0.28 (0.15–0.36) 0.768 1.76 0.03–69.74
Killip class III, n (%) 16 (25.8) 0.110 2.85 0.78–10.24
CSHA-CFS score 6, n (%) 22 (35.5) 0.059 3.24 0.96–11.55
Therapeutic intervention
Primary PCI 42 (67.7) 0.027* 0.07 0.07–0.86
Mechanical ventilation, n (%) 9 (14.5) 0.044* 4.37 1.05–18.35
Inotropes, n (%) 18 (29.0) <0.001* 21.48 5.28–115.18
Diuretics, n (%) 28 (45.2) 0.844 0.89 0.26–2.94
Blood transfusion, n (%) 4 (6.5) <0.001* 62.67 9.34–1274.78
Clinical outcomes
In-hospital death, n (%) 14 (22.6) – – –
Transfer to hospital/nursing home, n (%) 8 (12.9) – – –
Failure of discharge to home, n (%) 22 (35.5) – – –
Continuous variables are expressed as mean  standard deviation or median (ﬁrst-third quartile) and categorical variables as number (%).
Univariate logistic regression analyses.
OR, odds ratio; CI, conﬁdence interval; BMI, body mass index; ESRD, end-stage renal disease; HD, hemodialysis; CHF, congestive heart failure; PCI, percutaneous coronary
intervention; CABG, coronary artery bypass grafting; PMI, pacemaker implantation; BP, blood pressure; WBC, white blood cell; LVEF, left ventricular ejection fraction; CSHA-CFS,
Canadian Study of Health and Aging Clinical Frailty Scale; N/A, not analyzed.
* p < 0.05.
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and altered/loss of consciousness (n = 4). The median number of leads
with ST segment elevation was 3 and the maximum amplitude of ST
segment elevation was 0.28 mV (Table 1). The presumed locations of
infarcted area were: the anterior wall (n = 25), the inferior wall
(n = 24), the posterior/lateral wall (n = 12), and the global wall (n = 1).
Sixteen patients (25.8%) were classiﬁed as Killip class III or IV, and
35.5% has a CSHA-CFS score of 6. Hypoalbuminemia was the only
baseline independent variable signiﬁcantly associated with in-
hospital mortality on univariate analysis.
Primary PCI was performed in 42 patients (67.7%), and receiving
conservative therapy only was associated with in-hospital
mortality. Mechanical ventilation (required in 14.5% of patients),
inotropic support (required in 29.0% of patients), and blood
transfusion (required in 6.5% of patients) were also associated with
in-hospital mortality. There were 14 in-hospital deaths, which
were due to ventricular rupture (n = 3), low output and pulmonary
edema (n = 6), bradycardia (n = 1), ventricular ﬁbrillation (n = 2),cerebral infarction (n = 1), and possible infection (n = 1). Twenty-
two patients (35.5%) failed to discharge to home.
In the subgroup that underwent primary PCI (n = 42, Supple-
mentary Table 1), multi-vessel disease including left main disease
was found in 27 patients (64.3%). The infarct-related artery was the
left main trunk to proximal left anterior descending artery in four
patients (9.5%), none of whom died during hospitalization. Stent
implantation was performed in 35 patients (83.3%), and coronary
interventions other than stent implantation (balloon dilatation or
thrombus aspiration only) were associated with in-hospital
mortality. TIMI ﬂow grade II after PCI (n = 8, 19.0%) and use of
intra-aortic balloon pumping (n = 10, 23.8%) were associated with
in-hospital mortality.
Primary PCI was performed less frequently in patients with
a CHSA-CFS score of 6 (50.0% versus 77.5%, p = 0.046, Supplemen-
tary Fig. 1A). In patients with a CHSA-CFS score of 6, performing
primary PCI may be related to lower in-hospital mortality, although
not signiﬁcantly (18.8% versus 54.6%, p = 0.183, Supplementary
Table 2
Multivariate analyses for prediction of in-hospital death and failure of discharge to home.
In-hospital mortality Failure of discharge to home
p OR 95% CI p OR 95% CI
Female – – – 0.184 2.95 0.60–16.53
BMI 0.782 0.96 0.68–1.28 <0.001* 0.49 0.26–0.76
WBC count 0.458 0.90 0.68–1.17 0.397 1.14 0.85–1.58
Hemoglobin – – – 0.643 0.89 0.3–1.43
Troponin I 0.046* 1.02 1.00–1.06 0.362 1.02 0.99–1.06
Albumin 0.035* 0.16 0.02–0.88 0.181 0.22 0.22–1.57
Killip class III 0.051 6.08 0.99–50.90 – – –
LVEF – – – 0.587 0.26 0.02–1.85
CSHA-CFS score 6 0.028* 6.38 1.21–44.7 0.002* 16.69 2.67–175.02
Logistic regression analyses.
OR, odds ratio; CI, conﬁdence interval; BMI, body mass index; WBC, white blood cell; LVEF, left ventricular ejection fraction; CSHA-CFS, Canadian Study of Health and
Aging Clinical Frailty Scale.
* p < 0.05.
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performing primary PCI may be related to a lower incidence of
failure of discharge to home (12.9% versus 55.6%, p = 0.159,
Supplementary Fig. 1C), although not signiﬁcantly.
Logistic regression analyses for prediction of in-hospital mortality and
failure of discharge to home
The median length of hospital stay was 15 days (8–23 days).
Univariate analyses showed that lower BMI (p = 0.107), higher
white blood cell count (p = 0.130), higher serum troponin I level
(p = 0.060), lower serum albumin level (p = 0.008), Killip class III
(p = 0.110), and CSHA-CFS score 6 (p = 0.059) were signiﬁcantly
or marginally associated with in-hospital mortality (p < 0.15;
Table 1). Multivariate analysis identiﬁed a higher serum troponin I
level [p = 0.046, odds ratio (OR): 1.02] and lower serum albumin
level (p = 0.035, OR: 0.16), and CSHA-CFS score 6 (p = 0.028, OR:
6.38) as independent predictors of in-hospital mortality (Table 2).
Univariate analysis showed that female sex (p = 0.043), lower
BMI (p = 0.002), higher white blood cell count (p = 0.100), lower
hemoglobin concentration (p = 0.025), higher serum troponin I
level (p = 0.362), lower serum albumin level (p = 0.002), lower left
ventricular ejection fraction (p = 0.126), and higher CSHA-CFS
score (p = 0.004) were signiﬁcantly or marginally associated with
failure of discharge to home (p < 0.15, Supplementary Table 2).
Multivariate analysis identiﬁed a lower BMI (p < 0.001, OR: 0.49)
and CSHA-CFS score 6 (p = 0.002, OR: 16.69) as independent
predictors of failure of discharge to home (Table 2).
Discussion
The treatment of older patients with STEMI is challenging
because multiple factors that contribute to adverse outcomes
must be considered, including both revascularization procedure-
related events and non-cardiovascular events associated with
aging. This study demonstrated that in patients with STEMI aged
85 years, (1) hypoalbuminemia, a CSHA-CFS score of 6, and a
high serum troponin I level at presentation are independently
associated with in-hospital mortality, and (2) a lower BMI and
CSHA-CFS score of 6 are independently associated with failure of
discharge to home.
Known predictors of poor outcomes in patients with STEMI
Because our cohort included patients who received primary
PCI as well as patients who received conservative therapy only,
our potential predictors of interest were the variables at the time
of presentation, rather than procedure-related outcomes ortherapeutic interventions during hospitalization. Our results show
that the baseline serum troponin I level was independently
associated with in-hospital mortality. The serum troponin I level is
an established cardiac biomarker with high sensitivity and
speciﬁcity for cardiac injury [18]. A single serum troponin I level
measured at 4 h after reperfusion was well correlated with infarct
size [22]. The serum troponin I level increases earlier than other
cardiac biomarkers. In the present study, the baseline serum
troponin I level was signiﬁcantly associated with in-hospital
mortality, suggesting that this parameter reﬂects late arrival after
the onset. On the other hand, there were no signiﬁcant associations
between the time from onset to arrival and the clinical outcomes
(Table 1, Supplementary Table 2). Considering the modest
proportion of the patients with typical chest symptoms (61%),
we speculate that the time from onset to arrival informed by the
patients and/or their relatives were relatively unreliable in older
patients. A high Killip class was not signiﬁcantly associated with
in-hospital mortality in the present study (p = 0.051), but this
ﬁnding appears to be consistent with previous studies which
showed the impact of Killip class on mortality [1,2,7,23].
The signiﬁcant associations between in-hospital morality and
advanced therapies such as mechanical ventilation, inotropic
support, blood transfusion, or intra-aortic balloon pumping may be
predominantly attributable to the severity of the illness of the
patients who required these therapies, rather than a reﬂection of
procedure-related complications.
In the subgroup of patients who underwent primary PCI,
suboptimal TIMI ﬂow after PCI was associated with in-hospital
mortality on univariate analysis, which is also consistent with the
ﬁndings of previous studies [1,5,6]. On the other hand, stent
implantation was associated with a lower in-hospital mortality,
possibly because patients with suboptimal TIMI ﬂow after
thrombus aspiration or balloon dilatation were less likely to
undergo stent implantation.
Impact of hypoalbuminemia, BMI, and frailty on outcomes after STEMI
This is the ﬁrst study to show that hypoalbuminemia, a CSHA-
CFS score of 6, and lower BMI were independently associated
with early prognosis in patients aged 85 years with acute STEMI.
We consider that the roles of these factors to be especially
important in older patients with cardiovascular disease. Hypoal-
buminemia is an indicator of malnutrition, which may occur in
various conditions and is independently associated with all-cause
mortality in older people, especially in those with decreased
physical disability [24,25]. Hypoalbuminemia has been reported to
be associated with a poor prognosis in patients with heart failure,
together with anemia and renal failure [15,26,27]. Our study also
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with failure of discharge to home on univariate analysis.
Hypoalbuminemia may result from hemodilution in ﬂuid-over-
loaded patients [28] and may facilitate the development of
pulmonary edema in patients with low colloid osmotic pressure
[15]. We propose that older patients may be particularly
vulnerable to adverse outcomes in association with hemodynamic
changes, and that the adverse effects of hypoalbuminemia are
therefore particularly important in our cohort.
Increased frailty is associated with a higher mortality rate in
patients with coronary artery disease aged 70 years, in addition
to the previously validated risk factors for mortality [29]. Our study
demonstrated that increased frailty is an independent predictor of
both in-hospital mortality and failure of discharge to home in older
patients with STEMI. There are many methods of assessing frailty
[30]. CHSA-CFS is a measure for assessing frailty based on physical
function and level of independence with activities of daily living;
the frailty is classiﬁed using a seven point rating scale (1: very ﬁt, 2:
well without active disease, 3: well with treated comorbid disease,
4: apparently vulnerable, 5: mildly frail, 6: moderately frail, and 7:
severely frail) [30]. In this study we used the CSHA-CFS score
because it has a simple, distinct demarcation line, with a score of
6 indicating that help is needed with both instrumental and non-
instrumental activities of daily living, including activities such as
eating or bathing.
The impact of BMI on mortality after STEMI has previously been
studied. Patients with lower BMI demonstrated worse outcomes
after STEMI; however, these patients were older and this ﬁnding
may have been confounded by age [14,31,32]; generally, older
patients included in clinical studies had lower BMI than younger
patients. In the present study, BMI was signiﬁcantly associated
with failure of discharge to home after STEMI in patients with the
limited range of age (85–94 years); this ﬁnding implies the
importance of BMI itself in this cohort.
Failure of discharge to home is our novel dependent variable.
Clinically, explanation of this outcome to patients or their relatives
may be particularly important in this cohort because failure of
discharge to home occurs more frequently in older patients than
younger patients. The ﬁndings that frailty and lower BMI were
associated with failure of discharge to home in older patients with
STEMI may be useful in deciding on better in-hospital manage-
ment (such as early rehabilitation or feeding) in order to reduce
this outcome.
Relationship between therapeutic strategies, frailty and clinical
outcomes
Performing PCI was reported to be associated with better
outcomes in older patients with acute coronary syndrome [33]. In
our study, primary PCI was performed less frequently in patients
with a CHSA-CFS score of 6 (Supplementary Fig. 1A), presumably
because physicians might have expected poor clinical outcomes in
‘‘apparently’’ frail patients despite maximal invasive therapy. In
patients with a CHSA-CFS score of 6, performing PCI might have
reduced in-hospital mortality (Supplementary Fig. 1B). On the
other hand, in patients with a CHSA-CFS score of <6 (i.e. less frail
patients), performing primary PCI might have reduced incidence
of failure of discharge to home (Supplementary Fig. 1C). We
speculated that performing primary PCI for less frail older patients
might have facilitated early rehabilitation, resulting in early
recoveries of patients’ physical condition.
Limitations
This study has several limitations. First, it was a single-center
study, with a relatively small number of patients. However, thebaseline serum albumin level, CSHA-CFS score, and BMI were
signiﬁcant predictors of early prognosis despite the small
number of patients. Second, many patients were lost to
follow-up within 1 month, and mortality after discharge could
not be analyzed. Survival analysis over a longer period may have
yielded different ﬁndings. However, in older patients, who may
die from a number of causes, longer-term analyses may obscure
the direct impact of STEMI on mortality. Third, the retrospective
nature of the study and the lack of a standardized treatment
protocol in terms of deciding on primary PCI versus conservative
treatment may have introduced bias into statistical analyses. We
believe that the ﬁndings of this study can be used to plan further
multi-center, prospective studies. Fourth, because our current
study was aimed to determine the candidate predictors obtained
before performing PCI, the impact of primary PCI on the clinical
outcome was not clariﬁed. Instead we stratiﬁed the patients into
two groups according to their frailty (CHSA-CFS score of 6, or
<6) to consider the roles of primary PCI. To clarify the role(s) of
PCI, we should adjust the background characteristics of the
patients who are assigned to either of the treatments using
randomization, stratiﬁcation, propensity score matching, all of
which may require a larger number of patients. Finally, the
association between hypoalbuminemia and ﬂuid status was not
evaluated by measurement of neurohormone levels (such as
brain-natriuretic peptide) because these data were not available
for a substantial proportion of patients. Neurohormone levels
were therefore not included as independent variables in the
analysis.
Conclusion
Hypoalbuminemia, a CSHA-CFS score of 6, and higher
baseline serum troponin I level were signiﬁcantly associated
with in-hospital mortality in patients with STEMI aged 85 years.
Lower BMI and a CSHA-CFS score of 6 were signiﬁcantly
associated with failure of discharge to home. These ﬁndings
suggest that the serum albumin level, CSHA-CFS score, and
BMI are associated with early outcomes in older patients with
STEMI.
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